Guildford, UK, 20 May 2008: ReNeuron Group plc (LSE: RENE.L) today welcomes Parliament’s decision to approve research on stem cells derived from human-animal hybrid embryos. The decision represents the first round of votes on a number of provisions in, and amendments to, the Human Fertilisation and Embryology Bill, drafted to reform existing embryology laws in the UK.
